Vimarsana
Biggest News Aggregation in the World

Page 11 - Jonathan Arnold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Arnold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Arnold Today - Breaking & Trending Today

Denmark says damage to Nord Stream pipeline in Baltic Sea was 'deliberate' - Vimarsana News

Denmark says damage to Nord Stream pipeline in Baltic Sea was 'deliberate'

'This is not an earthquake,' says seismologist after 2 blasts damage pipeline

Qiagen to Develop Companion Dx for New Parkinson's Drug - Vimarsana News

Qiagen to Develop Companion Dx for New Parkinson's Drug

Qiagen and Neuron23 are working together to develop a companion diagnostic (companion Dx) for Neuron23's LRRK2 inhibitor for Parkinson's disease.

Qiagen, Neuron23 Partner for NGS-Based Parkinson's Disease Companion Diagnostic - Vimarsana News

Qiagen, Neuron23 Partner for NGS-Based Parkinson's Disease Companion Diagnostic

The collaboration will expand Qiagen's NGS testing portfolio for precision medicine beyond oncology into neurology applications.

QIAGEN N.V.: QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug - Vimarsana News

QIAGEN N.V.: QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing

Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug - Vimarsana News

Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug

/PRNewswire/ -- Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and...